Cryptocurrency & Digital Assets

Twenty teams, a historic solo sailor, and returning champions prepare to battle the elements in Asia's premier offshore race from Hong Kong to the Philippines.

As Beijing weaponizes rare earths, one company is already producing the critical alloys America's military needs, sidestepping a decades-long dependency.

ECGI Holdings is testing a platform to turn mortgages into digital tokens, a move that could disrupt the $2.2 trillion US mortgage industry. Here's how.

After a transformational CEO retires, Byrna Technologies bets on new leadership to navigate the booming, competitive less-lethal defense market.

The neurohealth firm surpassed revenue estimates and hit positive cash flow, but a dynamic competitive landscape and CEO transition loom ahead of its earnings call.

A new agreement could see South Korea's INNOSPACE launch from Canada, positioning Spaceport Nova Scotia as a key player in the global space race.

Amid a strategic overhaul, Hepion Pharmaceuticals is licensing a novel RNA-based liquid biopsy, aiming to transform early liver cancer detection.

The 155-year-old snack maker updates its beloved animal crackers with a new name, healthier recipe, and a mission to boost children's reading skills.

As oral GLP-1s enter the market, companies offer digital coaching to boost drug efficacy and justify soaring costs for employers and health plans.

A new partnership fuses marketing muscle with AI tech to launch a health platform in China, but it faces major regulatory and privacy hurdles.

With a new focus and fresh capital, Trigon Metals begins a key drilling campaign at its Addana project, betting on Moroccan silver to power the future.

As SIGA prepares to unveil its 2025 financials, investors are focused on the future of its Tpoxx contracts and its role in global biodefense strategy.

In its first year post-Comcast, Versant Media battles linear TV declines with a bold digital pivot, a new dividend, and a $1 billion stock buyback.

A significant order for critical Tomahawk missile parts sends Mobix Labs' stock soaring, highlighting the firm's key role in a surging defense market.

Amid a booming gene therapy market, Oxford Biomedica Solutions launches key investor events to showcase its strategy and secure its leadership position.

The digital asset giant is delisting from Toronto to streamline costs, a move that reshapes its buyback plan and how Canadian investors trade its stock.

A novel inhaled RNA therapy for a specific group of cystic fibrosis patients gains EMA fast-track status, promising accelerated access to new treatment.

New research reveals a media blind spot for hearing loss, fueling stigma. A new campaign aims to change the picture and normalize hearing aids for millions.

At ECR 2026, Subtle Medical showcases AI that boosts existing scanners, expands into CT, and promises faster, clearer diagnostics for patients.

A new report reveals Canadians are overwhelmed by scams, making them vulnerable to AI-driven fraud. Is a national strategy enough to fight back?